DexCom, Inc.DXCM
Price$86.23Intrinsic value$138.6761% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $138.67median of 6 methods · middle span $85-$176based on filings through 30 Jun 2026
Market Price $86.23Price as of 1 Oct 2026
Margin of Safety +60.8%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 19.7% (near-term consensus, capped) · years 2–5: 21.5%/yr (balance of the path).21.2% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 619.3%Yr 717.1%Yr 814.8%Yr 912.6%Yr 1010.4%
21.5% → 10.4%
Years 11–20: glide to long-run rate
Per-year rates
Yr 119.6%Yr 128.9%Yr 138.2%Yr 147.4%Yr 156.7%Yr 166.0%Yr 175.2%Yr 184.5%Yr 193.7%Yr 203.0%
10.4% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 2 windows (5/6y) (limited history)10.4%
Discount rate (cost of equity) 10.7%
Volatility vs market (adjusted beta)1.27

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetDexCom, Inc.DXCMHealth Care
Valuation
P/E34.1×
P/S6.7×
P/B13.1×
EV / Revenue6.7×
EV / EBITDA—
Profitability
Gross margin60.1%
Operating margin19.6%
Net margin20.1%
FCF margin28.3%
Returns
ROE38.1%
ROA15.5%
ROIC34.5%
Growth
Revenue growth (YoY)23.2%
5-yr fwd EPS growth21.2%
Financial strength
Debt / Equity0.53×
Current ratio1.73×
Altman Z-Score7.6
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.